Mitoxantrone Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 2 mg/mL
Reference Brands: Novantrone (USA)
Category: Oncology Cancer Care
Mitoxantrone (brand name Novantrone® and generics) is an antineoplastic (chemotherapy) medication used to treat certain cancers like acute nonlymphocytic leukemia (ANLL), advanced prostate cancer, and selected multiple sclerosis (MS) cases by slowing down abnormal cell growth and suppressing an overactive immune system. It is delivered as an intravenous infusion in a clinical setting. Mitoxantrone is available in Injection and strengths such as 2 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Mitoxantrone is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Mitoxantrone can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Mitoxantrone hydrochloride is an antineoplastic chemotherapy medication widely used in Oncology Cancer Care for treating various malignant conditions. It is most commonly prescribed for acute non-lymphocytic leukemia, advanced hormone-refractory prostate cancer, and selected severe cases of multiple sclerosis where other therapies have not been effective. Mitoxantrone works by binding to DNA and inhibiting topoisomerase II, an essential enzyme involved in DNA replication and repair. This action disrupts the growth and division of rapidly multiplying cancer cells, ultimately leading to their destruction. The drug is administered strictly by intravenous infusion under medical supervision, ensuring controlled dosing and monitoring for potential side effects. In oncology settings, mitoxantrone is often used in combination with other chemotherapeutic agents to increase treatment effectiveness. It is known for its deep blue coloration and is typically supplied as a 2 mg/mL injection solution in single-dose or multi-dose vials. While effective, mitoxantrone requires careful monitoring due to the risk of cardiotoxicity, bone marrow suppression, and cumulative dose limitations. Despite these considerations, it remains an important treatment option in modern cancer therapy and is widely used in many global treatment protocols.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Mitoxantrone is used to treat acute non-lymphocytic leukemia, advanced hormone-refractory prostate cancer, and selected severe forms of multiple sclerosis where other treatments have failed or are not suitable.
Mitoxantrone is made from a synthetic anthracenedione compound that disrupts DNA and RNA synthesis, leading to the inhibition of cancer cell growth.
The trade name most commonly associated with mitoxantrone is Novantrone.
Mitoxantrone and Novantrone have been manufactured by several pharmaceutical companies, including original brand manufacturers and multiple generic producers for hospital use.
The generic name is Mitoxantrone hydrochloride.
The primary brand name is Novantrone.
Mitoxantrone is manufactured by various licensed pharmaceutical companies across the United States, Europe, and India depending on the brand or generic supplier.
Related Products
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Mercaptopurine
Strength:
50 mg
Form: Tablets / Oral suspension
Reference Brands: Purinethol (USA), Purixan (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
